Overexpression of protein kinase B/AKT induces phosphorylation of p70S6K and 4E-BP1 in goat fetal fibroblasts

被引:3
作者
Ma, K. L. [1 ]
Nyamtsengel, V. [1 ]
Bao, W. L. [1 ]
Lian, M. Y. [1 ]
Wang, W. P. [1 ]
Wang, Y. F. [1 ]
Wang, X. [1 ]
Wang, Z. G. [1 ]
机构
[1] Inner Mongolia Univ, Coll Life Sci, Hohhot, Peoples R China
关键词
Protein kinase B (PKB)/AKT; Fetal fibroblasts; Mammalian target of rapamycin (mTOR); AKT overexpression; Inner Mongolia Cashmere goat; THERAPEUTIC TARGET; SIGNALING PATHWAY; MAMMALIAN TARGET; AKT; MTOR; ACTIVATION; DEFICIENCY; IDENTIFICATION; RESISTANCE; RAPAMYCIN;
D O I
10.4238/2014.November.27.22
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein kinases regulate many processes, including cell growth, metabolism, molecular interactions, and cell proliferation. Protein kinase B (PKB)/AKT (v-AKT mouse thymoma viral oncogene homolog) is an upstream component of mammalian target of rapamycin (mTOR) signaling and mediates pathophysiological processes in several signaling pathways. This study aimed to construct and overexpress a eukaryotic goat AKT expression vector in goat fetal fibroblasts and examine the effects of AKT on the phosphorylation of p70S6K and 4E-BP1. AKT was subcloned into the expression vector pIRES2-DsRed2 to generate pIRES2-DsRed2-AKT, which was transfected into goat fetal fibroblasts with Lipofectamine (TM) 2000. AKT was measured by reverse transcription-polymerase chain reaction in the transgenic cells, and the expression of AKT and phosphorylation of p70S6K (Thr389) and 4E-BP1 (Thr37/46) were analyzed by Western blot. Cell clones that stably emitted red fluorescence were obtained after transfection for 48 h, and the exogenous gene was verified. Exogenous AKT was transcribed, and AKT was overexpressed, inducing the phosphorylation of p70S6K (Thr389) and 4E-BP1 (Thr37/46) in goat fetal fibroblasts. Thus, the overexpression of AKT activates mTOR signaling in goat cells.
引用
收藏
页码:9931 / 9938
页数:8
相关论文
共 29 条
  • [1] mTOR signaling for biological control and cancer
    Alayev, Anya
    Holz, Marina K.
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2013, 228 (08) : 1658 - 1664
  • [2] Barrett D, 2012, PEDIATR DRUGS, V14, P299, DOI 10.2165/11594740-000000000-00000
  • [3] The AKTion in non-canonical insulin signaling
    Cheng, Zhiyong
    White, Morris F.
    [J]. NATURE MEDICINE, 2012, 18 (03) : 351 - 353
  • [4] The role of the NFκB signalling pathway in cancer
    Cortes Sempere, Maria
    Rodriguez Fanjul, Vanesa
    Sanchez Perez, Isabel
    Perona, Rosario
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2008, 10 (03) : 143 - 147
  • [5] Mechanisms and consequences of activation of protein kinase B/Akt
    Downward, J
    [J]. CURRENT OPINION IN CELL BIOLOGY, 1998, 10 (02) : 262 - 267
  • [6] p53 Regulation of the IGF-1/AKT/mTOR Pathways and the Endosomal Compartment
    Feng, Zhaohui
    [J]. COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2010, 2 (02): : a001057
  • [7] mTOR-Dependent regulation of ribosomal gene transcription requires S6K1 and is mediated by phosphorylation of the carboxy-terminal activation domain of the nucleolar transcription factor UBF
    Hannan, KM
    Brandenburger, Y
    Jenkins, A
    Sharkey, K
    Cavanaugh, A
    Rothblum, L
    Moss, T
    Poortinga, G
    McArthur, GA
    Pearson, RB
    Hannan, RD
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (23) : 8862 - 8877
  • [8] Identification of S6 kinase 1 as a novel mammalian target of rapamycin (mTOR)-phosphorylating kinase
    Holz, MK
    Blenis, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (28) : 26089 - 26093
  • [9] The TSC1-TSC2 complex is required for proper activation of mTOR complex 2
    Huang, Jingxiang
    Dibble, Christian C.
    Matsuzaki, Mika
    Manning, Brendan D.
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2008, 28 (12) : 4104 - 4115
  • [10] TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
    Inoki, K
    Li, Y
    Zhu, TQ
    Wu, J
    Guan, KL
    [J]. NATURE CELL BIOLOGY, 2002, 4 (09) : 648 - 657